Ponatinib and blinatumomab for Philadelphia chromosome-positive acute lymphoblastic leukaemia: a US, single-centre, single-arm, phase 2 trial.
Elias Jabbour,Nicholas J Short,Nitin Jain,Xuelin Huang,Guillermo Montalban-Bravo,Pinaki Banerjee, Katayoun Rezvani,Xianli Jiang,Kun Hee Kim,Rashmi Kanagal-Shamanna,Joseph D Khoury, Keyur Patel,Tapan M Kadia,Naval Daver,Kelly Chien,Yesid Alvarado,Guillermo Garcia-Manero,Ghayas C Issa,Fadi G Haddad,Monica Kwari,Jennifer Thankachan,Ricardo Delumpa,Walid Macaron,Rebecca Garris,Marina Konopleva,Farhad Ravandi,Hagop Kantarjian The Lancet. Haematology（2022）
摘要
Takeda Oncology and Amgen.
更多查看译文
AI 理解论文
溯源树
样例
